Mustang Bio regains compliance with Nasdaq minimum stockholders' equity requirement; listing matters closed

MUSTANG BIO, INC.

Received Feb 26, 2025 notice from Nasdaq confirming compliance with minimum stockholders' equity rule (Rule 5550(b)(1)).
Previously regained compliance with minimum bid price rule; now meets all Nasdaq Capital Market listing criteria.
Subject to Panel Monitor for one year through Feb 26, 2026; non-compliance triggers hearing without plan submission.
Press release issued March 5, 2025 announcing the compliance determination.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.